All Companies

KVUECongressional Stock Trades

Kenvue Inc.

Perfumes, Cosmetics & Other Toilet Preparations

Congressional stock trades in Kenvue Inc. (KVUE) from House and Senate STOCK Act filings. See which members of Congress bought or sold, disclosed amounts, and filing dates.

Total Trades

15

Politicians Trading

8

Last Traded

Aug 5, 2026

Trading History

PoliticianNotifiedTradedTypeAmountChange
Gilbert Ray Cisneros, Jr.DSep 4, 2026Jul 17, 2026Sell$1,001 - $15,000-6.16%
Kevin HernRAug 10, 2026Aug 5, 2026Sell$1,001 - $15,000-9.46%
Gilbert Ray Cisneros, Jr.DFeb 13, 2026Jan 9, 2026Sell$1,001 - $15,000+5.82%
Julia LetlowRJan 13, 2026Oct 1, 2025Sell$1,001 - $15,000+12.37%
Lisa C. McClainRNov 21, 2025Oct 31, 2025Sell$1,001 - $15,000+23.94%
Lisa C. McClainRNov 21, 2025Oct 30, 2025Sell$1,001 - $15,000+25.07%
Val T. HoyleDOct 10, 2025Sep 23, 2025Sell$1,001 - $15,000+3.31%
Scott FranklinRJul 14, 2025Jun 16, 2025Sell$1,001 - $15,000-17.74%

Price History

About Kenvue Inc.

Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of categories within consumer health, such as cough, cold and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Kenvue announced November 2025 that it signed a deal to be fully acquired by Kimberly-Clark with the deal expected to close during the second half of 2026.